Centogene N.v. buy krebskrebs
Start price
27.07.20
/
50%
€11.90
Target price
04.11.21
€20.00
Performance (%)
-31.43%
End price
05.11.21
€8.16
Summary
This prediction ended on 05.11.21 with a price of €8.16. The BUY prediction by krebskrebs for Centogene N.v. performed very badly with a performance of -31.43%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Centogene N.v. | - | - | - | - |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% | 58.522% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% | 95.184% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% | 49.093% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% | 60.886% |
Comments by krebskrebs for this prediction
In the thread Centogene N.v. diskutieren
Buy mit Kursziel 20,0
In the thread Trading Centogene N.v.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten